CLINICAL AND LABORATORY FEATURES OF CORONARY ARTERY ANEURYSMS IN KAWASAKI DISEASE
##plugins.themes.vojs.article.main##
Abstract
Objective: describe clinical and laboratory features of coronary artery aneurysms (CAA) in Kawasaki disease.
Patients and methods: 545 patiens with Kawasaki disease at Cardiovascular Center – Vietnam National Children’s Hospital between January 2019 and June 2022.
Results: Patients were classifed as 4 groups: no involvement, small aneurysm, medium aneurysm, large or giant aneurysm (GAA). The rates of 4 groups were: 44.6%, 19.4%, 18.2%, 7%. The average age at diagnosis of 12.6 months, 49.4% under 12 months, the ratio of male: female approximates 1.5: 1, 11.7% had atypical Kawasaki disease with lowest in no involvement group and highets in GAA group. Day at diagnosis, day of IVIG, total fever duration, IVIG-nonresponsive, the white blood cell count pre-IVIG, CRP pre-IVIG, platelets post-IVIG increased gradually with levels of CAA, but hemoglobin pre-IVIG, albumin decreased with levels of CAA, statistically signifcant differences between four groups (p<0.05).
Conclusions: In the subacute phage, there is a high rate of CAA. It had higher duration of diagnosis, IVIG resistance, white blood cell count, CRP and lower albumin, hemoglobin, age with another groups. The inflammatory response status increases with the level of CAA. There are statistically signifcant differences in some clinical and labotory variables in four groups.
##plugins.themes.vojs.article.details##
Keywords
Kawasaki disease, level of coronary artery aneurysm
References
2. Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110(17): 2747-2771. https://doi.org/10.1161/01.cir.0000145143.19711.78
3. McCrindle BW, Rowley AH, Newburger JW et al. Diagnosis, Treatment, and Long - Term Management of Kawasaki Disease: A Scientifc Statement for Health Professionals From the American Heart Association. Circulation 2017;135(17):e927-e999. https://doi.org/10.1161/cir.0000000000000484
4. Makino N, Nakamura Y, Yashiro M et al. Descriptive Epidemiology of Kawasaki Disease in Japan, 2011-2012: From the Results of the 22nd Nationwide Survey. J Epidemiol 2015;25(3):239-245. https://doi.org/10.2188/jea.je20140089
5. Kim JJ, Hong YM, Yun SW et al. Assessment of risk factors for Korean children with Kawasaki disease. Pediatr Cardiol 2012;33(4):513-520.https://doi.org/10.1007/s00246-011-0143-1
6. Lee J, Kim GB, Kwon BS et al. Two Cases of Super-Giant Coronary Aneurysms after Kawasaki Disease. Korean Circ J 2014;44(1):54-58. https://doi.org/10.4070/kcj.2014.44.1.54
7. Garrido-García LM, Moran E, YamazakiNakashimada M et al. Giant coronary artery aneurysms complicating Kawasaki disease in Mexican children. Cardiol Young 2018;28(3):386-390. https://doi.org/10.1017/s1047951117001470
8. Dietz SM, Kuipers IM, Tacke CEA et al. Giant aneurysms: A gender-specifc complication of Kawasaki disease? J Cardiol 2017;70(4):359-365. https://doi.org/10.1016/j.jjcc.2016.12.014
9. Pham TN. Characteristics of coronary artery aneurysm in Kawasaki disease unresponsive to immunoglobulin therapy.
10. Onouchi Y, Ozaki K, Burns JC et al. A genome-wide association study identifes three new risk loci for Kawasaki disease. Nat Genet 2012;44(5):517-521. https://doi.org/10.1038/ng.2220
11. Chen S, Dong Y, Kiuchi MG et al. Coronary artery complication in Kawasaki disease and the importance of early interventaion: a system review and meta-analysis. JAMA Pediatr 2016;170(12):1156-1163.https://doi.org/10.1001/jamapediatrics.2016.2055
12. McCrindle BW, Manlhiot C, Newburger JW et al. Medium‐Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry. J Am Heart Assoc 2020;9(15):e016440. https://doi.org/10.1161/jaha.119.016440
13. Masuzawa Y, Mori M, Hara T, et al. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin - unresponsive Kawasaki disease. Ther Apher Dial 2015;19(2):171-177.https://doi.org/10.1111/1744-9987.12235